First Australian National Trans Mental Health Study

May 5, 2014 updated by: Zoë Hyde, Curtin University

A Mixed-Methods Study of Mental Health and Associated Factors in Transgender and Transsexual (Trans) People

This is an Internet-based survey of transgender and transsexual (trans) people aged 18 years and older living in Australia. This population has received limited attention from public health researchers, planners, and practitioners. However, a growing body of evidence suggests that trans people experience disparities in several important areas of health compared with the population generally. In particular, trans people are more likely to experience mental health problems (notably depression and anxiety disorders), use alcohol, tobacco, and illicit drugs, and think about or attempt suicide. Additionally, trans people commonly report that their physical and mental health needs are not met, and underutilise preventive health care.

Participants were recruited using several non-probability sampling techniques, (including purposive sampling and snowball sampling), because random sampling is not possible with this population. Medical, social, support, and advocacy networks used by trans people were used to promote the study. A mixed quantitative and qualitative methodology was used. Validated quantitative instruments were used to obtain measures of health and well-being, which will be compared against population norms. Qualitative items complement these measures, providing rich experiential data.

The investigators hypothesised that:

  • the prevalence of depressive and anxiety disorders will be higher than for the population generally, and that these conditions will commonly be undiagnosed and untreated;
  • depressive and anxiety disorders will be associated with risky behaviours, such as tobacco, alcohol, and illicit drug use; and,
  • trans people will report poor relationships with medical practitioners.

The investigators hypothesised that poor mental health is a consequence of several interrelated factors: body dysphoria (as a consequence of experiencing difficulty accessing medical treatment to alter sexual characteristics); societal discrimination and stigma (including harassment and violence); institutionalised discrimination (including difficulty changing identifying documents, and exclusion of surgical procedures and related treatments from public and private health systems); social isolation; and the belief held by many clinicians that transsexualism is a mental disorder (which may be a barrier to trans people forming trusting relationships with medical practitioners).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

946

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Western Australia
      • Perth, Western Australia, Australia, 6102
        • Curtin University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This is a study of trans people living in Australia aged 18 years or older. The investigators used the term trans in an inclusive way, and included people who use (or used) words like transsexual, transgender, sistergirl, brotherboy, androgynous, or genderqueer to describe themselves. All trans people, including those who just describe themselves as men or women were encouraged to participate.

Description

Inclusion Criteria:

  • Live in Australia
  • Self-identify as trans

Exclusion Criteria:

  • Aged less than 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Transgender and Transsexual People
Transgender and transsexual (trans) people aged 18 years or older living in Australia were invited to complete a questionnaire assessing a range of mental and physical health domains.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of depressive and anxiety disorders
Time Frame: At time of entry into study (cross-sectional)
Assessed by self-report, and with the Patient Health Questionnaire (PHQ)
At time of entry into study (cross-sectional)
Perceived physical and mental health status
Time Frame: At time of entry into study (cross-sectional)
Assessed with the 36-item Short Form Health Survey (SF-36)
At time of entry into study (cross-sectional)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of alcohol, tobacco, and illicit drugs
Time Frame: At time of entry into study (cross-sectional)
Assessed by self-report
At time of entry into study (cross-sectional)
Patient-doctor relationship between trans people and their general practitioners, and doctors generally
Time Frame: At time of entry into study (cross-sectional)
Assessed with the Patient-Doctor Relationship Questionnaire (PDRQ-9) and other quantitative and qualitative questions
At time of entry into study (cross-sectional)
Body image
Time Frame: At time of entry into study (cross-sectional)
Assessed with the Body Image Quality of Life Inventory (BIQLI)
At time of entry into study (cross-sectional)
Factors that encourage and discourage trans people from accessing health care
Time Frame: At time of entry into study (cross-sectional)
Assessed with qualitative questions
At time of entry into study (cross-sectional)
Factors that protect and promote mental health in trans people
Time Frame: At time of entry into study (cross-sectional)
Assessed with qualitative questions
At time of entry into study (cross-sectional)
Use of hormone therapy and desire for, and uptake of transition-related surgery
Time Frame: At time of entry into study (cross-sectional)
Assessed with quantitative and qualitative questions
At time of entry into study (cross-sectional)
Experiences of discrimination and harassment
Time Frame: At time of entry into study (cross-sectional)
Assessed with quantitative and qualitative questions
At time of entry into study (cross-sectional)
Desire to, and success changing identifying documentation
Time Frame: At time of entry into study (cross-sectional)
Assessed with quantitative and qualitative questions
At time of entry into study (cross-sectional)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zoë Hyde, MPH PhD, Curtin University
  • Principal Investigator: Maryanne Doherty, MSc PhD, Curtin University
  • Principal Investigator: Peter Tilley, MPsych, Curtin University
  • Principal Investigator: Kieran A. McCaul, MPH PhD, The University of Western Australia
  • Principal Investigator: Rosanna Rooney, MPsych PhD, Curtin University
  • Principal Investigator: Jonine Jancey, PhD, Curtin University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

April 16, 2014

First Submitted That Met QC Criteria

April 18, 2014

First Posted (Estimate)

April 21, 2014

Study Record Updates

Last Update Posted (Estimate)

May 6, 2014

Last Update Submitted That Met QC Criteria

May 5, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • CB:gc:6722

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transsexualism

Clinical Trials on questionnaire

3
Subscribe